You are here

ABP 980

FDA stalls yet another Herceptin copycat, issuing response letter to Amgen/Allergan

Endpoints

Fri, 06/1/18 - 10:40 pm

complete response letter

Amgen and Allergan Hopeful that Herceptin Biosimilar Approval Will Be Around the Corner

Xtalks

Mon, 03/26/18 - 09:36 am

As Roche wades biosimilar waters, more competitors circle Herceptin

BioPharma Dive

Wed, 08/2/17 - 09:28 pm

Amgen and Allergan Study Finds Biosimilar Comparable to Herceptin

WSJ Online

Fri, 07/22/16 - 09:49 am